Commentary

The China Neonatal Genome Project: towards a new future in the treatment of genetic diseases

  • Wenhao ZHOU
Expand
  • Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou510620, Guangdong, China

Received date: 2024-04-10

  Online published: 2024-05-10

Abstract

With the advancement of science and technology, screening and diagnostic techniques for neonatal genetic diseases have made great leaps forward, especially the application of next-generation sequencing (NGS) technology, which has greatly improved the efficiency and accuracy of clinical applications. However, in the face of rapid diagnosis, it has become a new challenge to provide effective treatments to improve the overall prognosis of children.This article will start from the China Neonatal Genome Project, comprehensively and in-depth discuss the current status of newborn genetic disease screening and treatment, focus on the key issues of personalized treatment research and application, and propose efforts for future directions.

Cite this article

Wenhao ZHOU . The China Neonatal Genome Project: towards a new future in the treatment of genetic diseases[J]. Journal of Clinical Pediatrics, 2024 , 42(5) : 379 -383 . DOI: 10.12372/jcp.2024.24e0329

References

[1] Wu B, Kang W, Wang Y, et al. Application of full-spectrum rapid clinical genome sequencing improves diagnostic rate and clinical outcomes in critically ill infants in the China Neonatal Genomes Project[J]. Crit Care Med, 2021, 49(10): 1674-1683.
[2] National Organization for Rare Diseases. Global Genes Project[EB/OL]. https://rarediseases.org/
[3] Wang H, Qian Y, Lu Y, et al. Clinical utility of 24-h rapid trio-exome sequencing for critically ill infants[J]. NPJ Genom Med, 2020, 5: 20.
[4] Tan TY, Dillon OJ, Stark Z, et al. Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions[J]. JAMA Pediatr, 2017, 171(9): 855-862.
[5] Meng L, Pammi M, Saronwala A, et al. Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management[J]. JAMA Pediatr, 2017, 171(12): e173438.
[6] 中国遗传学会遗传咨询分会. 中国新生儿基因组计划[DB/OL]. (2016) [2022-03-07]. http://www.cbgc.org.cn/projects/2016/0817/569.html?1487814155.
[7] Genetic Counseling Branch of Chinese Genetic Society. China Neonatal Genome Project[DB/OL]. (2016) [2022-03-07]. http://www.cbgc.org.cn/projects/2016/0817/569.html?148781415.
[8] Wojcik MH, Gold NB. Implications of genomic newborn screening for infant mortality[J]. Int J Neonatal Screen, 2023, 9(1): 12.
[9] Xiao T, Ni Q, Chen H, et al. High-risk phenotypes of genetic disease in a neonatal intensive care unit population[J]. Chin Med J (Engl), 2022, 135(5): 625-627.
[10] Wang J, Zhou WH. Epigenetic clocks in the pediatric population: when and why they tick?[J]. Chin Med J (Engl), 2021, 134(24): 2901-2910.
[11] Huang S, Liu S, Huang M, et al.. The Born in Guangzhou Cohort Study enables generational genetic discoveries[J]. Nature, 2024, 626(7999): 565-573.
[12] Zhu Y, Hu L, Yang L, et al. Association between expanded genomic sequencing combined with hearing screening and detection of hearing loss among newborns in a neonatal intensive care unit[J]. JAMA Netw Open, 2022, 5(7): e2220986.
[13] Tong F, Wang J, Xiao R, et al. Application of next generation sequencing in the screening of monogenic diseases in China, 2021: a consensus among Chinese newborn screening experts[J]. World J Pediatr, 2022, 18(4): 235-242.
[14] Singh S, Ojodu J, Kemper AR, et al. Implementation of newborn screening for conditions in the United States first recommended during 2010-2018[J]. Int J Neonatal Screen, 2023, 9(2): 20.
[15] Dong X, Xiao T, Chen B, et al. Precision medicine via the integration of phenotype-genotype information in neonatal genome project[J]. 自然科学基础研究: 英文版, 2022.
[16] Yang L, Kong Y, Dong X, et al. Clinical and genetic spectrum of a large cohort of children with epilepsy in China[J]. Genet Med, 2019, 21(3): 564-571.
[17] Yang L, Liu X, Li Z, et al.. Genetic aetiology of early infant deaths in a neonatal intensive care unit[J]. J Med Genet, 2020, 57(3): 169-177.
[18] Mei H, Dong X, Wu B, et al. Clinical and genetic etiologies of neonatal unconjugated hyperbilirubinemia in the China Neonatal Genomes Project[J]. J Pediatr, 2022, 243: 53-60.
[19] Bainbridge MN, Wiszniewski W, Murdock DR, et al. Whole-genome sequencing for optimized patient management[J]. Sci Transl Med, 2011, 3(87): 87re3.
Outlines

/